🇺🇸 FDA
Patent

US 7728104

Process for preparing glycopeptide phosphonate derivatives

granted A61KA61K38/00A61P

Quick answer

US patent 7728104 (Process for preparing glycopeptide phosphonate derivatives) held by Theravance, Inc. expires Mon May 27 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Jun 01 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 27 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K38/00, A61P, A61P31/00, A61P31/04